Pernix Therapeutics Inc. Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pernix Therapeutics (PTX) Posts Q1 Loss of 62c/Share
May 1, 2015 6:52 AM EDTPernix Therapeutics (NASDAQ: PTX) reported Q1 EPS of ($0.62), which may not compare with the analyst estimate of ($0.02). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $34.55 million.
On a non-GAAP basis, 1Q 2015 adjusted net loss was $4.0 million versus... More
